Skip to content
Surf Wiki
Save to docs
geography/united-states

From Surf Wiki (app.surf) — the open knowledge base

Combat Methamphetamine Epidemic Act of 2005

US law


Summary

US law

FieldValue
shorttitleCombat Methamphetamine Epidemic Act of 2005
othershorttitlesCurbing Production of Methamphetamine Bill
longtitleAn Act to further regulate and punish illicit conduct relating to methamphetamine, and for other purposes.
colloquialacronymCMEA
nicknameMethamphetamine Epidemic Elimination Act
enacted by109th
effective dateMarch 9, 2006
public law urlhttp://www.gpo.gov/fdsys/pkg/STATUTE-120/pdf/STATUTE-120-Pg192.pdf
cite public law109-177
cite statutes at largeaka 120 Stat. 256
title amended
sections created
sections amended
leghisturlhttp://thomas.loc.gov/cgi-bin/bdquery/z?d109:HR03889:@@@R
introducedinHouse
introducedbill
introducedbyMark Souder (R–IN)
introduceddateSeptember 22, 2005
committeesHouse Energy and Commerce, House Judiciary, House International Relations, House Transportation and Infrastructure
passedbody1House
passeddate1July 21, 2005
passedvote1257-171, , in lieu of
passedbody2Senate
passedas2
passeddate2July 29, 2005
passedvote2Passed unanimous consent, in lieu of
conferencedateDecember 8, 2005
passedbody3House
passeddate3December 14, 2005
passedvote3251-174, , in lieu of
agreedbody3
agreeddate3
agreedvote3
agreedbody4
agreeddate4
agreedvote4
passedbody4Senate
passeddate4March 2, 2006
passedvote489-10, , in lieu of
signedpresidentGeorge W. Bush
signeddateMarch 9, 2006
unsignedpresident
unsigneddate
vetoedpresident
vetoeddate
overriddenbody1
overriddendate1
overriddenvote1
overriddenbody2
overriddendate2
overriddenvote2

| cite statutes at large = aka 120 Stat. 256 The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs:

  • ephedrine
  • pseudoephedrine
  • phenylpropanolamine (no longer OTC due to a proposed increased risk of stroke in younger women) Retail provisions of the CMEA include daily sales limits and 30-day purchase limits, placement of product out of direct customer access, sales logbooks, customer ID verification, employee training, and self-certification of regulated sellers. The CMEA is found as Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005 (H.R. 3199). The last provisions of the law took effect on 30 September 2006.

Justification

Ephedrine, pseudoephedrine, and phenylpropanolamine are precursor chemicals used in the illicit manufacture of methamphetamine or amphetamine. They are also common ingredients used to make cough, cold, and allergy products. It was argued that the CMEA would curtail the clandestine production of methamphetamine. The U.S. Department of Justice claimed that states that had enacted similar or more restrictive retail regulations saw dramatic drops in the numbers of small clandestine labs.

Provisions

"The CMEA requires record-keeping and identification of all sales and reports to law enforcement of any 'suspicious' transactions. Purchasers are limited to '3.6 grams of pseudoephedrine base' per day and 9 grams per month. (Buying more than that is a federal misdemeanor.)"

The statute also includes the following requirements for merchants who sell these products:

  • A retrievable record of all purchases identifying the name and address of each party to be kept for two years
  • Required verification of proof of identity of all purchasers
  • Required protection and disclosure methods in the collection of personal information
  • Reports to the Attorney General of any suspicious payments or disappearances of the regulated products
  • Required training of employees with regard to the requirements of the CMEA; Retailer must self-certify as to training and compliance
  • Non-liquid dose form of regulated product may only be sold in unit dose blister packs
  • Regulated products are to be sold behind the counter or in a locked cabinet in such a way as to restrict public access
  • Daily sales of regulated products not to exceed 3.6 grams without regard to the number of transactions
  • 30 day (not monthly) sales limit not to exceed 7.5 grams if sold by mail-order or "mobile retail vendor"
  • 30 day purchase limit not to exceed 9 grams of pseudoephedrine base in regulated products (misdemeanor possession offense under 21 USC 844a for the individual who buys it)
  • Prescriptions are exempt from logbook requirements.

First arrest

In September 2006, Tim Naveau was arrested and charged with a Class-B misdemeanor for purchasing Claritin-D. Naveau takes one tablet of Claritin D each day to combat allergies, and he "had stocked up on the allergy medication because his teenage son, who was also an allergy sufferer, needed several packages because he was headed off to a church camp."

References

References

  1. (2006-10-18). "The Combat Meth Act of 2005: Assessment of Annual Needs - Questions and Answers". U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control.
  2. Roots, Roger (2011-04-05) [http://archive.lewrockwell.com/orig8/roots6.1.1.html Cooking Meth: How Government Manufactured a Drug Epidemic], ''[[LewRockwell.com]]''
  3. Balko, Radley. (2006-12-24). "Man Arrested For Allergies". Reason Magazine.
  4. Barrilleaux, Amy. (2006-09-30). "New law could mean bad news for allergy sufferers". News Channel 8, WQAD.
Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about Combat Methamphetamine Epidemic Act of 2005 — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report